Skip to content

Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer

Unknown statusNot applicableNCT05494281
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Chronic postoperative pain (CPP) remains a disturbing and obscure clinical problem. The hypothesis of this trial is that a peripheral block of the serratus anterior plane block type preoperatively after a modified radical mastectomy makes it possible to reduce the intensity and incidence of chronic post-surgical pain in breast cancer.

Study details

Official title
Serratus Anterior Plane Block to Prevent Chronic Pain in Breast Cancer Surgery: A Randomized Controlled Trial
Conditions
Interventions
  • Procedure: Serratus Anterior Plane Block with local anesthetic
  • Procedure: Serratus Anterior Plane Block with saline solution
Sponsor
Moroccan Society of Surgery
Start date
2022-08-01
Primary completion
2023-02-01
Sex
Female
Age range
from 18 Years to 70 Years
Results posted
No results posted in this snapshot
Countries
Morocco
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Having an age greater than or equal to 18 years and less than 70 years * Having given written consent for participation in the study and the use of personal and medical data * Having a physical status of class I, II or III of the American Society of Anesthesiologists Exclusion Criteria: * Patients who expressed their refusal to participate in the study * Patients unable to express their non-objection to participation in the study * American Society of Anesthesiologists class \> III patients * Known allergy to local anesthetics * A contraindication to performing a peripheral nerve block (such as an acquired, constitutional or drug clotting disorder or infection at the nerve block injection site) * Morbid obesity (body mass index greater than 40 kg/m²) * Chronic use of opioids * Inability to use the patient controlled analgesia device * The existence of preoperative pain * History of neuropathy or neurological pathology * The existence of catastrophism or anxiety diagnosed preoperatively

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05494281